BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37579733)

  • 21. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
    Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
    Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The expression of hTERT and p53 protein in pre-malignant and malignant lesions of human oral mucosa].
    Wu GY; Zhu L; Feng ZQ; Peng T; Qi B
    Shanghai Kou Qiang Yi Xue; 2005 Feb; 14(1):51-4. PubMed ID: 15747015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
    Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
    Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
    Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma.
    Lin SW; Abnet CC; Freedman ND; Murphy G; Risques R; Prunkard D; Rabinovitch P; Pan QJ; Roth MJ; Wang GQ; Wei WQ; Lu N; Taylor PR; Qiao YL; Dawsey SM
    BMC Cancer; 2013 Dec; 13():578. PubMed ID: 24308314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mode of origin of esophageal squamous cell carcinoma--serial histopathologic and immunohistochemical studies].
    Kuwano H; Ikebe M; Baba K; Kitamura K; To Y; Adachi Y; Sugimachi K
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):937-9. PubMed ID: 1470159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
    Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
    Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
    Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
    Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: a clinicopathologic and immunohistochemical study of 15 cases.
    Brien TP; Farraye FA; Odze RD
    Mod Pathol; 2001 May; 14(5):389-96. PubMed ID: 11353047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The expression characteristics and clinical significance of candidate molecular markers in vocal cord leukoplakia].
    Cui WX; Xu W; Yang QW; Li YR; Hu R; Cheng LY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):592-596. PubMed ID: 30121997
    [No Abstract]   [Full Text] [Related]  

  • 33. Detecting p53 immunoexpression in esophageal mucosa with exfoliative cytology in individuals at risk for squamous cell carcinoma of the esophagus.
    Lopes AB; Müller LB; Reichert R; Moraes CM; Capra AM; Prolla JC; Diehl AR; Meurer L; de Barros SG; Fagundes RB
    Acta Cytol; 2010; 54(1):31-8. PubMed ID: 20306985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of p53 protein expression in Barrett esophagus.
    Krothapalli M; Kini JR; Kini H; Sahu KK; Shenoy S; Krishna SG; Tantry BV
    Indian J Pathol Microbiol; 2018; 61(2):170-175. PubMed ID: 29676351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
    Kerdpon D; Rich AM; Reade PC
    Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological studies of esophageal carcinoma in achalasia: analyses of carcinogenesis using histological and immunohistochemical procedures.
    Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Oshiba G; Kise Y; Kajiwara H; Tsuchida T; Tanaka M; Tajima T; Makuuchi H
    Anticancer Res; 2000; 20(5C):3717-22. PubMed ID: 11268444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 overexpression in the multistep process of esophageal carcinogenesis.
    Parenti AR; Rugge M; Frizzera E; Ruol A; Noventa F; Ancona E; Ninfo V
    Am J Surg Pathol; 1995 Dec; 19(12):1418-22. PubMed ID: 7503363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China.
    Chen H; Wang LD; Guo M; Gao SG; Guo HQ; Fan ZM; Li JL
    World J Gastroenterol; 2003 Jan; 9(1):16-21. PubMed ID: 12508343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Karashima R; Imamura Y; Ida S; Ishimoto T; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Med Oncol; 2013 Dec; 30(4):728. PubMed ID: 24026664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
    Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
    Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.